Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12610000186055
Ethics application status
Approved
Date submitted
18/02/2010
Date registered
2/03/2010
Date last updated
28/11/2019
Date data sharing statement initially provided
28/11/2019
Date results provided
28/11/2019
Type of registration
Prospectively registered
Titles & IDs
Public title
Investigation of endothelial function in populations at high cardiovascular risk
Query!
Scientific title
cross-sectional study of endothelium function in patients with type II diabetes and of high cardiovascular risk receiving standard clinical care
Query!
Secondary ID [1]
1447
0
none
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Vascular function
256828
0
Query!
Condition category
Condition code
Cardiovascular
256975
256975
0
0
Query!
Diseases of the vasculature and circulation including the lymphatic system
Query!
Metabolic and Endocrine
257041
257041
0
0
Query!
Diabetes
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
a) Participant involvement is 1 visit (4 hrs) with fasting 6hrs immediately prior to visit
b) Strain gauge plethysmography and peripheral arterial tone technology (EndoPAT) will be used to assess endothelial function
c) Vasodilators sodium nitroprusside (Nitropress: 2 micrograms/min, 4 micrograms/min and 8 micrograms/min) and acetylcholine chloride (Miochol-E: 9.25 micrograms/min, 18.5 micrograms/min, 37 micrograms/min) will be delivered for 2 min each via the brachial artery during the strain gauge plethysmography. This will enable measurement of endothelial mediated vasodilation
Query!
Intervention code [1]
256031
0
Early detection / Screening
Query!
Comparator / control treatment
The untreated arm (contralateral to the cannulated arm) will be the comparator for the strain gauge plethysmography test. The test will be performed on this arm in the absence of brachial artery cannulation and therefore sodium nitroprusside and acetylcholine chloride. Healthy volunteers will be the comparator group.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
257865
0
Vascular endothelial function using strain gauge plethysmography and peripheral arterial tone technology
Query!
Assessment method [1]
257865
0
Query!
Timepoint [1]
257865
0
All measures are assessed on the day of the single visit
Query!
Secondary outcome [1]
263318
0
Blood analysis using in vitro laboratory assays for inflammatory marker determination, Endothelial Progenitor Cell identification and lipid measurements.
Query!
Assessment method [1]
263318
0
Query!
Timepoint [1]
263318
0
measures are assessed on the day of the single visit or at a later date using fresh or frozen plasma collected on the day of the single visit from the cannulated arm
Query!
Eligibility
Key inclusion criteria
Study Group:
Type II diabetes
4 to 6 months post acute coronary syndrome
Comparator Group
of general good health and non-smoking
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
75
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Study group:
type 1 Diabetes
Impaired liver or renal function
Uncontrolled hypertension
heart failure (class III or V)
Any other serious Illness
on more than 2 anti-diabetic drug treatments
Query!
Study design
Purpose
Screening
Query!
Duration
Cross-sectional
Query!
Selection
Defined population
Query!
Timing
Prospective
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
30/03/2010
Query!
Actual
30/03/2010
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
1/03/2011
Query!
Date of last data collection
Anticipated
Query!
Actual
18/11/2011
Query!
Sample size
Target
30
Query!
Accrual to date
Query!
Final
30
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Funding & Sponsors
Funding source category [1]
256535
0
Self funded/Unfunded
Query!
Name [1]
256535
0
Baker IDI Heart and Diabetes Research Institute
Query!
Address [1]
256535
0
75 Commercial rd, Melbourne, VIC 3004
Query!
Country [1]
256535
0
Australia
Query!
Primary sponsor type
Other Collaborative groups
Query!
Name
Baker IDI Heart and Diabetes Research Institute
Query!
Address
75 Commercial rd, Melbourne, VIC 3004
Query!
Country
Australia
Query!
Secondary sponsor category [1]
255876
0
None
Query!
Name [1]
255876
0
Query!
Address [1]
255876
0
Query!
Country [1]
255876
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
258588
0
The Alfred Human Research Ethics Committee
Query!
Ethics committee address [1]
258588
0
Alfred Hospital Commercial Rd Prahran, VIC 3181
Query!
Ethics committee country [1]
258588
0
Australia
Query!
Date submitted for ethics approval [1]
258588
0
12/01/2010
Query!
Approval date [1]
258588
0
11/03/2010
Query!
Ethics approval number [1]
258588
0
4/10 (Ref number for Alfred HREC)
Query!
Summary
Brief summary
Endothelial dysfunction is a disease process that occurs throughout the vascular system and results in abnormal regulation of blood vessel tone and the loss of atheroprotective properties of normal endothelium. The presence of endothelial dysfunction in coronary or peripheral arteries is an independent predictor of future cardiovascular events. While it is well known that vascular dysfunction is associated with type II diabetes, the effects of standard treatments for this disease such as statins and fibrates on vascular function is less clear. This is even more so for type II diabetes patients with acute coronary syndrome. The assessment of arterial endothelial function using strain gauge plethysmography is considered the “gold standard” of endothelial function testing. However, it is invasive and not applicable to large patient populations. Therefore, recent non-invasive techniques such as Endo-PAT have been developed to overcome these shortfalls. Endo-PAT is a non-invasive peripheral arterial tonometer (PAT) which measures the changes in pulse wave amplitude (PWA) in the fingertip of the index finger. While Endo-PAT is approved by the U.S Food and Drug Authority, its reliability in detecting endothelial dysfunction in different patient cohorts is still being established. Aims: Our study aims to answer two research questions: Do patients at high cardiovascular risk under standard clinical care exhibit endothelial dysfunction? We will examine endothelial function using both forearm venous occlusion plethysmography and Endo-PAT. The second research question is how reliable is the EndoPAT device in detecting endothelial dysfunction compared to strain gauge plethysmography?
Query!
Trial website
Query!
Trial related presentations / publications
None
Query!
Public notes
Query!
Contacts
Principal investigator
Name
30840
0
Query!
Address
30840
0
Query!
Country
30840
0
Query!
Phone
30840
0
Query!
Fax
30840
0
Query!
Email
30840
0
Query!
Contact person for public queries
Name
14087
0
Dr Natalie Lumsden
Query!
Address
14087
0
Baker IDI Heart and Diabetes Research Institute
75 Commercial Rd, Melbourne, VIC, 3004
Query!
Country
14087
0
Australia
Query!
Phone
14087
0
+61 3 8532 1359
Query!
Fax
14087
0
Query!
Email
14087
0
[email protected]
Query!
Contact person for scientific queries
Name
5015
0
Dr Natalie Lumsden
Query!
Address
5015
0
Baker IDI Heart and Diabetes Research Institute
75 Commercial Rd, Melbourne, VIC, 3004
Query!
Country
5015
0
Australia
Query!
Phone
5015
0
+61 3 8532 1359
Query!
Fax
5015
0
Query!
Email
5015
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF